Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
India allows home delivery of clinical trial medications during COVID-19 pandemic lock down.
May 13, 2020
By: Contract Pharma
Contract Pharma Staff
Marken’s Direct-to-Patient (DTP) distribution services are now actively delivering to and from 94 cities in India and are expected to be available in 110 cities by the end of May. The service is in response to India’s government lock down, which has now been extended until May 18th. Marken’s deliveries of medicine to patients confined to their homes while enrolled in a clinical trial is a continuation of the company’s strategy to bring clinical trials closer to patient’s homes. Home delivery of clinical trial medications was not previously available in India prior to the COVID-19 pandemic. However, given the critical need to keep patients in their clinical trials, the government has now permitted the service to proceed. This was made possible due to Marken’s Standard Operating Procedures, data protection technology, adherence to Good Distribution Practices (GDP) and Good Clinical Practices (GCP). Marken is now serving 94 cities from their offices in Mumbai, New Delhi, Ahmedabad, Pune, Hyderabad, and Bangalore. Ariette Van Strien, President of Marken, said, “We are proud to offer new Direct to Patient services in India. Our global management technology which ensures patient privacy, coupled with our global logistics experience with home-based trials, have enabled us to add India to our long list of countries where DTP is possible. We intend to be the world leader in home-based clinical trial services which will allow our customers to move their new medicines through the pipeline as quickly as possible.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !